[go: up one dir, main page]

AU2001229679A1 - Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications - Google Patents

Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications

Info

Publication number
AU2001229679A1
AU2001229679A1 AU2001229679A AU2967901A AU2001229679A1 AU 2001229679 A1 AU2001229679 A1 AU 2001229679A1 AU 2001229679 A AU2001229679 A AU 2001229679A AU 2967901 A AU2967901 A AU 2967901A AU 2001229679 A1 AU2001229679 A1 AU 2001229679A1
Authority
AU
Australia
Prior art keywords
coenzyme
dosage forms
related applications
reduced form
high bioavailability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229679A
Inventor
Raj K. Chopra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/488,332 external-priority patent/US6740338B1/en
Application filed by Individual filed Critical Individual
Publication of AU2001229679A1 publication Critical patent/AU2001229679A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001229679A 2000-01-20 2001-01-18 Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications Abandoned AU2001229679A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09488332 2000-01-20
US09/488,332 US6740338B1 (en) 2000-01-20 2000-01-20 Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
US09637559 2000-08-11
US09/637,559 US8753675B1 (en) 2000-01-20 2000-08-11 Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
PCT/US2001/001997 WO2001052822A1 (en) 2000-01-20 2001-01-18 Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications

Publications (1)

Publication Number Publication Date
AU2001229679A1 true AU2001229679A1 (en) 2001-07-31

Family

ID=27049313

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229679A Abandoned AU2001229679A1 (en) 2000-01-20 2001-01-18 Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications

Country Status (5)

Country Link
US (1) US8753675B1 (en)
EP (1) EP1251834B1 (en)
AU (1) AU2001229679A1 (en)
CA (1) CA2397447C (en)
WO (1) WO2001052822A1 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010129A1 (en) 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa ESSENTIAL FATTY ACIDS IN THE THERAPY OF HEART INSUFFICIENCY AND HEART FAILURE
JP3742602B2 (en) * 2001-05-09 2006-02-08 株式会社カネカ Stable solution of reduced coenzyme Q
CA2443191A1 (en) 2001-05-10 2002-11-21 Kaneka Corporation Compositions for transmucosal administration containing coenzyme q as the active ingredient
JP2003026567A (en) * 2001-05-10 2003-01-29 Kanegafuchi Chem Ind Co Ltd Composition for administration to mucosa and containing coenzyme q as active ingredient
DE10133305B4 (en) 2001-07-12 2004-06-03 Aquanova German Solubilisate Technologies (Agt) Gmbh Ubiquinone concentrate
TWI310029B (en) * 2001-07-13 2009-05-21 Kaneka Corp
TWI235146B (en) 2001-07-16 2005-07-01 Kaneka Corp Method of stabilizing reduced coenzyme q10 and method of acidic crystallization
US20030044474A1 (en) * 2001-08-03 2003-03-06 Shaklee Corporation High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability
JP3822479B2 (en) 2001-10-10 2006-09-20 株式会社カネカ Stabilized composition of reduced coenzyme Q aqueous solution
TWI329510B (en) * 2001-10-10 2010-09-01 Kaneka Corp Method of stabilizing reduced coenzyme q10
TW200302056A (en) * 2002-01-18 2003-08-01 Kaneka Corp Method for stabilizing reduced coenzyme Q10 and composition therefor
TW200304372A (en) * 2002-03-20 2003-10-01 Kanegafuchi Chemical Ind Compositions for diabetes
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
AU2004277951B2 (en) 2003-09-29 2010-11-11 Soft Gel Technologies, Inc. Solubilized CoQ-10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
CN1909895A (en) * 2004-01-08 2007-02-07 株式会社钟化 Antiaging composition
US7708990B2 (en) 2004-03-23 2010-05-04 Kaneka Corporation Coenzyme Q compositions persisting in blood
EP1728506A1 (en) * 2004-03-23 2006-12-06 Kaneka Corporation Coenzyme q composition with long-term persistence in blood
WO2005097091A1 (en) * 2004-04-09 2005-10-20 Kaneka Corporation Composition comprising reduced-form coenzyme q10 and carotenoid compound
TW200603786A (en) * 2004-05-11 2006-02-01 Kaneka Corp Anti-fatigue composition
JP2006070016A (en) * 2004-08-02 2006-03-16 Kaneka Corp Whitening composition containing reduced coenzyme q
RU2007128342A (en) * 2004-12-24 2009-01-27 Канека Корпорейшн (Jp) A SOLID PRODUCT CONTAINING RESTORED CO-ENZYME Q10 AND METHOD OF PRODUCING IT
US8067217B2 (en) 2004-12-28 2011-11-29 Kaneka Corporation Method for preserving reduced coenzyme Q10
US20080254016A1 (en) * 2005-03-29 2008-10-16 Kaneka Corporation Composition For Increasing Anti-Oxidation Activity In Blood
CN1853728A (en) * 2005-04-19 2006-11-01 上海天博生物科技有限公司 Method prescription and use for improving medicine or nutrient oral absorption
EP2564843B1 (en) 2005-06-01 2018-12-26 Bioelectron Technology Corporation Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US20090226408A1 (en) * 2005-06-24 2009-09-10 Kaneka Corporation Anti-fatigue composition
DE102005032352A1 (en) * 2005-07-08 2007-01-11 Aquanova German Solubilisate Technologies (Agt) Gmbh Solubilizer for an active ingredient concentrate in the food industry comprises a St. John's wort extract, a roseda extract or a tarragon extract, a polysorbate emulsifier and water
LT1933821T (en) 2005-09-15 2020-11-10 Ptc Therapeutics, Inc. Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
WO2007034852A1 (en) * 2005-09-22 2007-03-29 Kaneka Corporation Composition for life extension and method of extending the life
JP5015548B2 (en) * 2005-10-31 2012-08-29 株式会社カネカ Method for stabilizing reduced coenzyme Q10
US8506956B2 (en) 2005-10-31 2013-08-13 Kaneka Corporation Method for stabilizing reduced coenzyme Q10
EP1986636B1 (en) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
TW200808344A (en) 2006-04-28 2008-02-16 Kaneka Corp Stabilization method of reduced coenzyme Q10
AU2007261943B2 (en) 2006-06-22 2012-11-01 Kaneka Corporation Reduced coenzyme Q10-containing composition and method for producing the same
US8642030B2 (en) * 2006-08-25 2014-02-04 Epc Europe Gmbh Compositions containing coenzyme Q-10 and dihydrolipoic acid
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
WO2008119605A1 (en) * 2007-04-02 2008-10-09 Unilever Plc Toothpaste composition
WO2009025277A1 (en) 2007-08-22 2009-02-26 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
WO2009044852A1 (en) * 2007-10-05 2009-04-09 Kaneka Corporation Method of producing reduced coenzyme q10
CN101307338B (en) 2008-07-17 2012-04-25 任雷 Preparation method of reduced coenzyme Q10
MX363223B (en) 2008-09-10 2019-03-15 Bioelectron Tech Corp TREATMENT OF GENERALIZED DISORDERS OF THE DEVELOPMENT WITH THERAPEUTICS WITH REDOX ACTIVITY.
CN101514148B (en) * 2009-03-27 2015-05-13 玉溪健坤生物药业有限公司 Method for preparing reduced coenzyme Q10
WO2011045934A1 (en) 2009-10-16 2011-04-21 株式会社カネカ Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same
US8557236B2 (en) 2010-02-09 2013-10-15 Vascure Natural LLC Cardiovascular support supplement and compositions and methods thereof
US11400058B2 (en) 2010-03-12 2022-08-02 Berg Llc Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof
JP5546935B2 (en) * 2010-04-20 2014-07-09 株式会社カネカ Reduced coenzyme Q10-containing composition and method for producing the same
IT1400695B1 (en) * 2010-06-21 2013-06-28 Labomar S R L PHARMACEUTICAL AND / OR NUTRACEUTICAL COMPOSITIONS CONTAINING ACTIVE INSOLUBLES IN WATER AND PROCEDURE TO OBTAIN THEM.
JP5344768B2 (en) * 2010-08-11 2013-11-20 クラシエフーズ株式会社 Coenzyme Q10 photodegradation inhibitor and oral composition
US9655849B2 (en) 2011-03-18 2017-05-23 Particle Dynamics International, Llc Solid particulate compositions comprising coenzyme Q10
EA201490047A1 (en) 2011-06-17 2014-08-29 Берг Ллк INHALATION PHARMACEUTICAL COMPOSITIONS
US20140107223A1 (en) * 2012-10-12 2014-04-17 Whitehill Oral Technologies, Inc. Topical ubiquinol supplement skin care compositions
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
ES2685329B1 (en) * 2017-03-30 2019-07-22 Phidinut S L Oral composition for deep mouth cleaning
ES2645028B2 (en) * 2017-10-13 2018-06-04 Maria D. GÓMEZ GARRE Single and stable pharmaceutical preparation containing berberine, in slow-release formulation, a statin and ubiquinol for the treatment of cardiovascular disease and associated risk factors
US11471426B2 (en) 2019-10-16 2022-10-18 American River Nutrition, Llc Compositions comprising quinone and/or quinol and methods of preparations and use thereof
DE102019218240A1 (en) * 2019-11-26 2021-05-27 Beiersdorf Ag Active ingredient combinations of ubiquinol and glyceryl stearate citrate and cosmetic or dermatological preparations containing such active ingredient combinations
US20240245628A1 (en) * 2023-01-03 2024-07-25 Bausch + Lomb Ireland Limited Compositions and methods for health comprising co-enzyme q10

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655005A5 (en) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION WITH METABOLIC AND ENERGY ACTION USABLE IN CARDIAC AND VASCULAR THERAPY.
EP0150688B1 (en) 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
IT1191608B (en) * 1985-02-01 1988-03-23 Zambon Spa PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL FORMS THAT CONTAIN IT
CA2007983C (en) 1989-01-18 1996-12-10 Michael S. Brown Coenzyme q10 with hmg-coa reductase inhibitors
US4929437A (en) * 1989-02-02 1990-05-29 Merck & Co., Inc. Coenzyme Q10 with HMG-CoA reductase inhibitors
US4933165A (en) 1989-01-18 1990-06-12 Merck & Co., Inc. Coenzyme Q10 with HMG-CoA reductase inhibitors
US5316765A (en) 1989-09-07 1994-05-31 Karl Folkers Foundation For Biomedical And Clinical Research Use of coenzyme Q10 in combination with HMG-CoA reductase inhibitor therapies
US5082650A (en) 1989-09-07 1992-01-21 Folkers Karl A Amelioration of reductions of coenzyme Q10 in cardiomyopathy patients receiving lovastatin
US5409693A (en) 1989-10-12 1995-04-25 Perricone; Nicholas V. Method for treating and preventing sunburn and sunburn damage to the skin
US5312819A (en) * 1990-08-20 1994-05-17 Sandoz Ltd. Pharmaceutical compositions comprising clozapine and a radical scavenger
SE9101642D0 (en) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab phospholipids
IT1275434B (en) * 1995-05-19 1997-08-07 Farmila Farma Milano PHARMACEUTICAL AND / OR DIETARY COMPOSITIONS WITH ANTIOXIDANT ACTIVITY
US6056971A (en) 1996-07-24 2000-05-02 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
JP3889481B2 (en) 1996-08-16 2007-03-07 株式会社カネカ Pharmaceutical composition
JP3926888B2 (en) 1997-05-27 2007-06-06 株式会社カネカ Cholesterol lowering agent
US6207137B1 (en) * 1997-06-12 2001-03-27 C.S. Bioscience, Inc. Dental formulation
AU9209898A (en) * 1997-09-02 1999-03-22 Ricex Company, Inc., The A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
US5908613A (en) * 1997-09-08 1999-06-01 Bozzacco; Craig Composition for the treatment and prevention of periodontal disease
US6066327A (en) * 1997-12-17 2000-05-23 Color Access, Inc. Antioxidant mixture
US6045826A (en) 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US6805880B1 (en) * 1999-08-20 2004-10-19 Ferrosan A/S Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress
US6998501B1 (en) * 1999-08-30 2006-02-14 Ocean Nutrition Canada Limited Nutritional supplement for lowering serum triglyceride and cholesterol levels
US6441050B1 (en) * 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities

Also Published As

Publication number Publication date
CA2397447A1 (en) 2001-07-26
EP1251834B1 (en) 2014-05-28
CA2397447C (en) 2009-08-11
US8753675B1 (en) 2014-06-17
EP1251834A1 (en) 2002-10-30
EP1251834A4 (en) 2008-11-05
WO2001052822A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
AU2001229679A1 (en) Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications
AU2002335536A1 (en) Pyrimidine compound and medicinal composition thereof
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001270778A1 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
AU2002255451A1 (en) Procaryotic libraries and uses
AU2001222986A1 (en) Dehydroascorbic acid formulations and uses thereof
AU2002234545A1 (en) Pharmaceutical preparation in the form of a suspension comprising an acid-labileactive ingredient
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
AU2002239933A1 (en) Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU2001249077A1 (en) Dense-plasma etching of inp-based materials using chlorine and nitrogen
AU2001297611A1 (en) Pharmaceutical uses and synthesis of diketopiperazines
AU2001284763A1 (en) Preparation of risperidone
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AUPQ760400A0 (en) Herbical formulations and methods of use thereof
AU2002338561A1 (en) Lipid producing cells and uses thereof
AU2000275966A1 (en) Pigmented compositions and articles of manufacture containing same
AU4449501A (en) Production and use of dissolved bioavailable selenium
AU2001295478A1 (en) Active metabolite of gepirone